# Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients

> **NCT02025335** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 199 (actual)

## Conditions studied

- Kidney Transplantation Recipients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02025335
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2015-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025335, "Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02025335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*